NR3C1 and myalgic encephalomeyelitis/chronic fatigue syndrome: A gene profiling clinical study has demonstrated a significant correlation between glucocorticoid receptor (NR3C1) expression and the exacerbation of PEM symptoms in ME/CFS patients [18].